ClinConnect ClinConnect Logo
Search / Trial NCT06355635

Application and Monitoring of Vasoactive and Inotrope Drugs

Launched by JOHANNES GUTENBERG UNIVERSITY MAINZ · Apr 5, 2024

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how doctors use and monitor certain medications called vasoactive and inotrope drugs in patients who are having non-cardiac surgeries and experiencing hemodynamic instability, which means their blood flow and pressure are not stable. The goal is to understand the current practices among anesthesiologists in Germany regarding these medications.

If you are an anesthesiologist in Germany, you might be eligible to participate in this study. The trial is currently recruiting participants, and it's a great opportunity for doctors to contribute to improving patient care. Participants in the trial will share their experiences and practices in using these medications, which could help enhance how patients are treated during surgery. It's important to note that only anesthesiologists who can fully respond to the study's questions are eligible to join.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • all anesthesiologists of germany
  • Exclusion Criteria:
  • not completely responses

About Johannes Gutenberg University Mainz

Johannes Gutenberg University Mainz, a leading research institution in Germany, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research and education to address critical health challenges. Its commitment to ethical standards and scientific rigor ensures that clinical trials are conducted with the utmost integrity, aiming to translate research findings into effective therapies and improved patient outcomes. Through its robust infrastructure and expert faculty, Johannes Gutenberg University Mainz plays a pivotal role in enhancing the landscape of clinical research and contributing to global health advancements.

Locations

Mainz, Rhineland Palatinate, Germany

Patients applied

0 patients applied

Trial Officials

Marc Kriege

Principal Investigator

University Medical Centre

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported